Rockwell Medical, Inc.
corporate_fare Company Profile
Rockwell Medical, Inc. (NASDAQ:RMTI) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 23 items for RMTI at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Rockwell Medical Reports Q4 & Full-Year 2025 Results: Achieves Adjusted EBITDA Profitability, Boosts Cash Position
- Rockwell Medical Reports Strong Preliminary Q4 & Full-Year 2025 Results with Positive Cash Flow and Improved Cash Position
- Rockwell Medical Extends DaVita Agreement with Favorable Product Price Increase
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$69.26M
Net Income
-$5.31M
Diluted EPS
-$0.15
Op. Cash Flow
-$659K
Free Cash Flow
-$1.2M
Gross Profit
$11.7M
Operating Income
-$4.69M
Cash & Equivalents
$10.71M
Total Debt
$8.83M
Debt / Equity
0.24×
Net Margin
-7.7%
Shares Outstanding
39.41M sh
Source: 10-K · filed 2026-03-26 · accession 0001628280-26-021186
show_chartPrice Chart
Loading chart...
feed RMTI - Filings & News (Page 2)
RMTI
Mar 26, 2026, 6:10 AM EDT
Price at Filing:
$0.797
Real-time Price:
$5.88
Change:
Reverse Stock Split
Market Cap:
$23.117M
RMTI
Jan 20, 2026, 6:32 AM EST
Price at Filing:
$1.08
Real-time Price:
$5.88
Change:
Reverse Stock Split
Market Cap:
$23.117M
RMTI
Jan 05, 2026, 6:33 AM EST
Price at Filing:
$0.8875
Real-time Price:
$5.88
Change:
Reverse Stock Split
Market Cap:
$23.117M